Risk of lymphoma in women with breast implants: Analysis of clinical studies

European Journal of Cancer Prevention

Volumn 21, Issue 3, 2012, Pages 274-280

  Largent, Joan ^a   Oefelein, Michael ^a   Kaplan, Hilton M ^a   Okerson, Ted ^a   Boyle, Peter ^b  

^a ALLERGAN INC   (United States)

^b INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

breast implants; epidemiology; lymphoma

Indexed keywords

ARTICLE; BREAST CANCER; BREAST ENDOPROSTHESIS; CANCER RISK; CONFIDENCE INTERVAL; HEALTH SURVEY; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; MEDICAL HISTORY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO;

ADULT; BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MIDDLE AGED; RISK ASSESSMENT; SEER PROGRAM; UNITED STATES;

EID: 84859334409     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328350b0ae     Document Type: Article

References (51)

1. Aguilera NS, Tavassoli FA, Chu WS, Abbondanzo SL (2000). T-cell lymphoma presenting in the breast: a histologic, immunophenotypic and molecular genetic study of four cases. Mod Pathol 13:599-605. (Pubitemid 30436794)
2. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (2009). SEER Cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute. Available at http://seer.cancer.gov/csr/1975-2007/. [Accessed 10 January 2012].
3. Anderson RN, Rosenberg HM (1988). Age standardization of death rates: impact of year 2000 standard. National vital statistics reports. 47: Hyattsville, MD: National Center for Health Statistics; 2000 US Standard Population (Census P25-1130); p. 3.
4. Bengtson BP, Van Natta BW, Murphy DK, Slicton A, Maxwell GP (2007). Style 410 highly cohesive silicone breast implant core study results at 3 years. Plast Reconstr Surg 120:40S-48S. (Pubitemid 350306657)
5. Bishara MR, Ross C, Sur M (2009). Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol 4:11.
6. Brinton LA, Brown SL, Colton T, Burich MC, Lubin J (2000). Characteristics of a population of women with breast implants compared with women seeking other types of plastic surgery. Plast Reconstr Surg 105:919-927. (Pubitemid 30158794)
7. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN (2001). Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol 11:248-256. (Pubitemid 32288854)
8. Brisson J, Holowaty EJ, Villeneuve PJ, Xie L, Ugnat AM, Latulippe L, Mao Y (2006). Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer 118:2854-2862. (Pubitemid 43673367)
9. Cook LS, Daling JR, Voigt LF, deHart MP, Malone KE, Stanford JL, et al. (1997). Characteristics of women with and without breast augmentation. JAMA 277:1612-1617. (Pubitemid 27231193)
10. Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, et al. (2006). New malignancies among cancer survivors: SEER cancer registries, 1973-2000. Bethesda, MD: National Cancer Institute; . NIH Publ. No. 05-5302.
11. Dean AG, Sullivan KM, Soe MM (2010). OpenEpi: Open source epidemiologic statistics for public health, version 2.3. Available at http://www.OpenEpi.com. [Accessed 21 July, 2010].
12. Deapen DM, Bernstein L, Brody GS (1997). Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles Study. Plast Reconstr Surg 99:1346-1353. (Pubitemid 27163517)
13. Deapen DM, Hirsch EM, Brody GS (2007). Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg 119:1987-1992. (Pubitemid 46847086)
14. De Jong D, Vasmel WL, de Boer JP, Verhave G, BarbéE, Casparie MK, van Leeuwen FE (2008). Anaplastic large-cell lymphoma in women with breast implants. JAMA 300:2030-2035.
15. Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP (2002). Lymphomas of the breast: primary and secondary involvement. Cancer 94:6-13. (Pubitemid 34049036)
16. Friis S, Hölmich LR, McLaughlin JK, Kjøller K, Fryzek JP, Henriksen TF, Olsen JH (2006). Cancer risk among Danish women with cosmetic breast implants. Int J Cancer 118:998-1003. (Pubitemid 43157677)
17. Fritzsche FR, Pahl S, Petersen I, Burkhardt M, Dankof A, Dietel M, Kristiansen G (2006). Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancera case report. Virchows Arch 449:561-564. (Pubitemid 44722325)
18. Fryzek JP, Weiderpass E, Signorello LB, Hakelius L, Lipworth L, Blot WJ, et al. (2000). Characteristics of women with cosmetic breast augmentation surgery compared with breast reduction surgery patients and women in the general population of Sweden. Ann Plast Surg 45:349-356.
19. Greenland S, Rothman KJ (2008). Measures of occurrence. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. 3rd ed. Philadelphia PA: Lippincott, Williams and Wilkins; pp. 32-50.
20. Gualco G, Chioato L, Harrington WJ Jr, Weiss LM, Bacchi CE (2009). Primary and secondary T-cell lymphomas of the breast: clinic-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol 17:301-306.
21. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361-1392. (Pubitemid 24273002)
22. Kelten C, Kabukcu S, Sen N, Teke Z, Yaren A, Erdem E, Duzcan E (2009). Secondary involvement of the breast in T-cell non-Hodgkin lymphoma, an unusual example mimicking inflammatory breast carcinoma. Arch Gynecol Obstet 280:149-152.
23. Krishnan B, Morgan GJ (2007). Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev 16:377-380. (Pubitemid 46548635)
24. Li S, Lee AK (2009). Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction? Int J Clin Exp Pathol 3:117-127.
25. Lim U, Morton LM, Subar AF, Baris D, Stolzenberg-Solomon R, Leitzman M, et al. (2007). Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 166:697-708. (Pubitemid 47347893)
26. Lipworth L, Tarone RE, Friis S, Ye W, Olsen JH, Nyren O, McLaughlin JK (2009a). Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study. Int J Cancer 124:490-493.
27. Lipworth L, Tarone RE, McLaughlin JK (2009b). Breast Implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg 123:790-793.
28. McLaughlin JK, Lipworth L, Fryzek JP, Ye W, Tarone RE, Nyren O (2006). Longterm cancer risk among Swedish women with cosmetic breast implants: an update of a nationwide study. J Natl Cancer Inst 98:557-560. (Pubitemid 43898819)
29. Mellemkjaer L, Kjøller K, Friis S, McLaughlin JK, Hegsted C, Winther JF, et al. (2000). Cancer occurrence after cosmetic breast implantation in Denmark. Int J Cancer 88:301-306.
30. Miranda RN, Lin L, Talwalkar SS, Manning JT, Medeiros LJ (2009). Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med 133:1383-1390.
31. Morton LM, Hartge P, Holford TR, Holly EA, Chiu BC, Vineis P, et al. (2005a). Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Cancer Epidemiol Biomarkers Prev 14:925-933. (Pubitemid 40478558)
32. Morton LM, Zheng T, Holford TR, Holly EA, Chiu BC, Costantini AS, et al. (2005b). InterLymph Consortium. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 6:469-476. (Pubitemid 40903627)
33. Morton LM,Wang SS, Devesa SS, Hartge P,Weisenburger DD, Linet MS (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107:265-276. (Pubitemid 43053551)
34. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, et al. (2007). Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 110:695-708. (Pubitemid 47105409)
35. Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ (2008). Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg 61:822-825. (Pubitemid 351970472)
36. Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2000 Census Data1). Available at http://seer.cancer.gov/registries/data-p.pdf. [Accessed 30 November, 2010].
37. Olack B, Gupta R, Brooks GS (2007). Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg 59:56-57. (Pubitemid 46987980)
38. Palmer RH, Vernersson E, Grabbe C, Hallberg B (2009). Anaplastic lymphoma kinase: signalling in development and disease. Biochem J 420:345-361.
39. Querfeld C, Khan I, Mahon B, Nelson BP, Rosen ST, Evens AM (2010). Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options. Oncology 24:574-587.
40. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A (2008). Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 21:455-463. (Pubitemid 351441035)
41. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A (2003). Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med 127:e115-e118.
42. Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, et al. (2008). International Peripheral T-Cell Lymphoma Project. ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK + ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 111: 5496-5504.
43. Spear SL, Murphy DK, Slicton A, Walker PS (2007). Inamed silicone breast implant core study results at 6 years. Plast Reconstr Surg 120:8S-16S. (Pubitemid 350306652)
44. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17. Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2009 Sub (1973-2007 varying) - Linked To County Attributes - Total US, 1969-2007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission.
45. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer. cancer.gov) SEER*Stat Database: Populations - Total US (1969-2007) - Linked To County Attributes - Total US, 1969-2007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released November 2009.
46. Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ (2008). Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol 32:1299-1309.
47. Troy JD, Hartge P, Weissfeld JL, Oken MM, Colditz GA, Mechanic LE, Morton LM (2010). Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol 171:1270-1281.
48. Wong AK, Lopategui J, Clancy S, Kulber D, Bose S (2008). Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol 32:1265-1268.
49. Wu XC, Andrews P, Chen VW, Groves FD (2009). Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences. Cancer Epidemiol 33:337-346.
50. Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang B, et al. (2004). Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women. Am J Epidemiol 160:766-773. (Pubitemid 39362214)
51. Zhang Y, Sanjose SD, Bracci PM, Morton LM,Wang R, Brennan P, et al. (2008). Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol 167:1321-1331. (Pubitemid 351770553)